Ryan Sullivan
2020
Compensation breakdown
| Option Awards | $528,088 |
|---|---|
| Salary | $437,107 |
| Stock Awards | $1,087,836 |
| Other | $89,942 |
| Total | $2,142,973 |
Sullivan received $1.1M in stock awards, accounting for 51% of the total pay in 2020.
Sullivan also received $528.1K in option awards, $437.1K in salary and $89.9K in other compensation.
Rankings
In 2020, Ryan Sullivan's compensation ranked 5,203rd out of 13,090 executives tracked by ExecPay. In other words, Sullivan earned more than 60.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,203 out of 13,090 | 60th |
Division Manufacturing | 2,140 out of 5,618 | 62nd |
Major group Chemicals And Allied Products | 855 out of 2,251 | 62nd |
Industry group Drugs | 736 out of 1,951 | 62nd |
Industry Pharmaceutical Preparations | 551 out of 1,456 | 62nd |
Pay ratio
| Ryan Sullivan's Pay | $2,142,973 |
|---|---|
| Median Employee's Pay | $267,493 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Ryan Sullivan was $2,142,973.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.
The ratio of Ryan Sullivan's pay to the pay of median employee was therefore 8 to one.
Sullivan's colleagues
We found six more compensation records of executives who worked with Ryan Sullivan at Intercept Pharmaceuticals in 2020.
2020
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2020
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2020
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2020
Richard Kim
Intercept Pharmaceuticals
Former President, U.S. Commercial & Strategic Marketing
2020
Lisa Bright
Intercept Pharmaceuticals
Former President, International
2020
Christian MAS
Intercept Pharmaceuticals